Post-marketing study to assess the effectiveness of doravirine-included in highly active antiretroviral therapy (HAART) in HIV-1 infected adult Chinese patients (MK-1439-088)

23/03/2023
07/05/2025
EU PAS number:
EUPAS103993
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

MK-1439-088-00-v1-Protocol_final redaction

English (1.02 MB - PDF) View document
Updated protocol

MK-1439-088-00-v2-Protocol_final redaction (002)

First published: 22/02/2024
English (1 MB - PDF) View document
Study results
Study report
Study report

MK-1439 P088 CSR_final-redaction.pdf

English (584.29 KB - PDF) View document
Other information